SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Marina Berenguer, John R. Lake, Transplantation of the Liver, 2015,

    CrossRef

  2. 2
    Evangelos Cholongitas, Chrysanthi Mamou, Kryssia I. Rodríguez-Castro, Patrizia Burra, Mammalian target of rapamycin inhibitors are associated with lower rates of hepatocellular carcinoma recurrence after liver transplantation: a systematic review, Transplant International, 2014, 27, 10
  3. 3
    G. Levy, F. G. Villamil, F. Nevens, H. J. Metselaar, P.-A. Clavien, G. Klintmalm, R. Jones, M. Migliaccio, H. Prestele, R. Orsenigo, REFINE: A Randomized Trial Comparing Cyclosporine A and Tacrolimus on Fibrosis After Liver Transplantation for Hepatitis C, American Journal of Transplantation, 2014, 14, 3
  4. 4
    Jérôme Dumortier, Ephrem Salamé, Bruno Roche, Monika Hurtova, Filomena Conti, Sylvie Radenne, Claire Vanlemmens, Georges-Philippe Pageaux, Faouzi Saliba, Didier Samuel, Philippe Compagnon, Martine Neau-Cransac, Yvon Calmus, Olivier Guillaud, Jean Gugenheim, Mario Altieri, François Durand, Jean Hardwigsen, Richard Lorho, Sébastien Dharancy, Vincent Leroy, Fabienne Di Giambattista, Christophe Duvoux, Severe fibrosis in patients with recurrent hepatitis C after liver transplantation: A French experience on 250 patients over 15 years (the Orfèvre study), Clinics and Research in Hepatology and Gastroenterology, 2014, 38, 3, 292

    CrossRef

  5. 5
    Manuel Rodríguez-Perálvarez, Giacomo Germani, Vasilios Papastergiou, Emmanuel Tsochatzis, Evangelos Thalassinos, Tu Vinh Luong, Nancy Rolando, Amar Paul Dhillon, David Patch, James O’Beirne, Douglas Thorburn, Andrew Kenneth Burroughs, Early tacrolimus exposure after liver transplantation: Relationship with moderate/severe acute rejection and long-term outcome, Journal of Hepatology, 2013, 58, 2, 262

    CrossRef

  6. You have free access to this content6
    Neil Mehta, Ryutaro Hirose, Immunosuppression: Conventions and controversies, Clinical Liver Disease, 2013, 2, 4
  7. 7
    Nobuhisa Akamatsu, Yasuhiko Sugawara, Living-Donor Liver Transplantation and Hepatitis C, HPB Surgery, 2013, 2013, 1

    CrossRef

  8. 8
    S. Sarwar, B. Carey, J.E. Hegarty, P.A. McCormick, Low incidence of Pneumocystis jirovecii pneumonia in an unprophylaxed liver transplant cohort, Transplant Infectious Disease, 2013, 15, 5
  9. 9
    Christophe Duvoux, Roberto Firpi, Gian L. Grazi, Gary Levy, Eberhard Renner, Federico Villamil, Recurrent hepatitis C virus infection post liver transplantation: impact of choice of calcineurin inhibitor, Transplant International, 2013, 26, 4
  10. 10
    Angel Rubín, Marina Berenguer, Trasplante hepático: inmunosupresión personalizada en pacientes con hepatitis C y carcinoma hepatocelular, Gastroenterología y Hepatología, 2013, 36, 1, 48

    CrossRef

  11. 11
    Jody C Olson, Russell H Wiesner, Immunomodulating therapy in liver transplantation: principles and practice, Immunotherapy, 2012, 4, 8, 793

    CrossRef

  12. 12
    Aaron James Chan, John R. Lake, Immunosuppression in HCV-positive liver-transplant recipients, Current Opinion in Organ Transplantation, 2012, 17, 6, 648

    CrossRef

  13. 13
    Nobuhisa Akamatsu, Yasuhiko Sugawara, Liver Transplantation and Hepatitis C, International Journal of Hepatology, 2012, 2012, 1

    CrossRef

  14. 14
    Manuel Rodríguez-Perálvarez, Giacomo Germani, Emmanuel Tsochatzis, Nancy Rolando, Tu Vinh Luong, Amar Paul Dhillon, Douglas Thorburn, James O’Beirne, David Patch, Andrew Kenneth Burroughs, Predicting severity and clinical course of acute rejection after liver transplantation using blood eosinophil count, Transplant International, 2012, 25, 5
  15. 15
    Marina Berenguer, Ramón Charco, Juan Manuel Pascasio, Jose Ignacio Herrero, Spanish society of liver transplantation (SETH) consensus recommendations on hepatitis C virus and liver transplantation, Liver International, 2012, 32, 5
  16. 16
    M. Rodríguez-Perálvarez, G. Germani, T. Darius, J. Lerut, E. Tsochatzis, A. K. Burroughs, Tacrolimus Trough Levels, Rejection and Renal Impairment in Liver Transplantation: A Systematic Review and Meta-Analysis, American Journal of Transplantation, 2012, 12, 10
  17. You have free access to this content17
    X. Forns, M. Navasa, Cyclosporine A or Tacrolimus for Hepatitis C Recurrence? An Old Debate, American Journal of Transplantation, 2011, 11, 8
  18. 18
    Evangelos Cholongitas, Vibhakorn Shusang, Giacomo Germani, Emmanuel Tsochatzis, Maria Luisa Raimondo, Laura Marelli, Marco Senzolo, Brian R. Davidson, David Patch, Keith Rolles, Andrew K. Burroughs, Long-term follow-up of immunosuppressive monotherapy in liver transplantation: tacrolimus and microemulsified cyclosporin, Clinical Transplantation, 2011, 25, 4
  19. 19
    Lutz Fischer, Pavel Trunečka, Bruno Gridelli, Andre Roy, Alessandro Vitale, Andrés Valdivieso, Evaristo Varo, Daniel Seehofer, Stephen Lynch, Didier Samuel, Bo-Goran Ericzon, Karim Boudjema, Carmen Karpf, Nasrullah Undre, Pharmacokinetics for once-daily versus twice-daily tacrolimus formulations in de novo liver transplantation: A randomized, open-label trial, Liver Transplantation, 2011, 17, 2
  20. 20
    Marina Berenguer, Viral hepatitis: Ciclosporin versus tacrolimus for HCV transplant recipients, Nature Reviews Gastroenterology & Hepatology, 2011, 8, 8, 422

    CrossRef

  21. 21
    Marina Berenguer, Victoria Aguilera, Fernando San Juan, Salvador Benlloch, Angel Rubin, Rafael López-Andujar, Angel Moya, Eugenia Pareja, Eva Montalva, Maria Yago, Manuel de Juan, José Mir, Martín Prieto, Effect of Calcineurin Inhibitors in the Outcome of Liver Transplantation in Hepatitis C Virus-Positive Recipients, Transplantation, 2010, 90, 11, 1204

    CrossRef

  22. 22
    Sandeep Mukherjee, Urmila Mukherjee, A Comprehensive Review of Immunosuppression Used for Liver Transplantation, Journal of Transplantation, 2009, 2009, 1

    CrossRef

  23. 23
    Susanne Beckebaum, Georgios C. Sotiropoulos, Christian G. Klein, Christoph E. Broelsch, Fuat Saner, Andreas Paul, Guido Gerken, Vito R. Cicinnati, Predictive Factors of Outcome in Patients Transplanted for Hepatitis B, Transplantation, 2009, 87, 6, 872

    CrossRef

  24. 24
    S. BECKEBAUM, C. KLEIN, J. VARGHESE, G. C. SOTIROPOULOS, F. SANER, K. SCHMITZ, G. GERKEN, A. PAUL, V. R. CICINNATI, Renal function and cardiovascular risk profile after conversion from ciclosporin to tacrolimus: prospective study in 80 liver transplant recipients, Alimentary Pharmacology & Therapeutics, 2009, 30, 8
  25. 25
    Felix Braun, Freya A. Goumas, Dieter C. Broering, Matthias Behrend, 2009,

    CrossRef

  26. 26
    Sandeep Mukherjee, Michael F. Sorrell, Controversies in Liver Transplantation for Hepatitis C, Gastroenterology, 2008, 134, 6, 1777

    CrossRef

  27. 27
    Thanh H.K. Nguyen, Keith Melancon, John Lake, William Payne, Abhinav Humar, Do graft type or donor source affect acute rejection rates after liver transplant: a multivariate analysis, Clinical Transplantation, 2008, 22, 5
  28. 28
    Edward J. Gane, The natural history of recurrent hepatitis C and what influences this, Liver Transplantation, 2008, 14, S2
  29. 29
    Jun Woong Moon, Su Jeong Song, Bo Kyung Koo, Young Min Cho, Hyeong Gon Yu, Short-term Effects and Side Effects of Tacrolimus for Behçet's Uveitis, Journal of the Korean Ophthalmological Society, 2007, 48, 12, 1654

    CrossRef

  30. 30
    Mubashir Khan, A Joseph Tector, Paul Y Kwo, Tacrolimus or microemulsified ciclosporin for immunosuppression after liver transplantation?, Nature Clinical Practice Gastroenterology & Hepatology, 2007, 4, 8, 424

    CrossRef

  31. 31
    Bradford Strijack, Paul A. Keown, Cyclosporine: Molecular Action to Clinical Therapeutics,
  32. 32
    Andrew K. Burroughs, James O'Beirne, Hepatic Transplantation,
  33. 33
    Russell H. Wiesner, Immunosuppression: The Global Picture,
  34. 34
    William J. Pitts, Immunosuppressive Agents for the Prevention of Transplantation Rejection, Burger's Medicinal Chemistry and Drug Discovery,
  35. 35
    Maria Pleguezuelo, Giacomo Germani, Andrew K Burroughs, Liver Transplantation: Prevention and Treatment of Rejection,
  36. 36
    Karen L. Hardinger, Daniel C. Brennan, Christina L.M. Klein, Maintenance Immunosuppressive Therapy,
  37. 37
    Palak J. Trivedi, James Neuberger, Managing Rejection,
  38. 38
    James F. Trotter, Rejection and Immunosuppression Trends in Liver Transplantation,